Role: External IP Director/Lead for clients across the pharma, biotechnology and tech spectrumResponsibilities include: • Manage existing portfolio and guide forward IP strategy for portfolio value maximization • Implement and coordinate invention identification and disclosure process • Set and manage internal legal budget and outside counsel budget • Negotiate and manage contracts (full gamut, from simple NDAs to in- and out-licensing) • Manage patent drafting and prosecution (whether performed internally and externally) • Lead and coordinate due diligence and other legal activities • Support C-suite strategic and tactical needs (e.g., BD activities, finance-related, government proceedings)

• Responsible for worldwide filing strategy and patent prosecution• In-licensed key technology and negotiated favorable maintenance of license under challenging financial conditions

• Serve as lead patent representative for select clients• Lead prosecution of hundreds of patent applications from initial draft to issue, including significant portion in the biologics space• Conduct patentability and freedom-to-operate searches, draft opinions

• Role: IP lead. I reported directly to the C-suite; regularly consulted on C-Suite issues due to business perspective and judgment• Role: Legal lead. Responsible for all outside counsel resources (corporate, general, litigation, compliance, all of which were separate)• Growth: expanded the Singulex portfolio from 58 patents and applications in March 2010 to 161 patents and applications by the end of 2014 (2.7x), while the budget increased only 1.2x over that period• Due diligence: conducted several due diligence reviews on various internal and external programs and four due diligence reviews of the entire portfolio for rounds of private funding and an attempted IPO. Included preparing the Singulex portfolio for outside review and conducting the internal and external reviews themselves• Contracts: responsible for initiation, execution and maintenance of all company contracts (for a ~$60M revenue company; >450 contracts per year), including negotiating solo in most instances and with appropriate shareholders when applicable• Strategy: responsible for worldwide filing strategy. Led effort to earn patents to highly valuable biomarkers with stiff competition from big players (e.g., Roche)• Budget: responsible for IP and all legal budgets and budget management; despite large portfolio growth (2.7x), reduced cost-per-application significantly resulting in only 1.2x IP budget growth; remained within budget each year despite the relative unpredictability of event timing during patent prosecution

After closure of the company, I was responsible for maintaining the IP portfolio until all IP assets were sold.

Role:• IP lead: during my tenure I reported directly to the Sr. VP R&D• Growth: expanded the ARYx portfolio from 133 patents and applications in August 2004 to >400 patents and applications by 2010 (~2.9x), while the budget increased only ~1.4x over that period • Due diligence: conducted well over a dozen due diligence reviews on three separate ARYx programs and several due diligence reviews of the entire portfolio for rounds of private funding and a Nov. 2007 IPO, which included preparing our portfolio for outside review and conducting the reviews themselves• IP protection: responsible for NDA negotiation, consummation, logging and archiving• Strategy: responsible for worldwide filing strategy• Member of Portfolio Management Committee, which is responsible for advancing or killing programs• Drafting: drafted most ARYx patent applications during my tenure• Prosecution: directed outside counsel resources for patent prosecution and opinion work• Budget: responsible for IP budget and budget management; remained within budget each year despite the relative unpredictability of event timing during patent prosecution• In-house resource development: managed the disclosure process to extract the maximum number of inventions from research and development; guided the development of in-house technical advisor and patent agent• Briefing: regularly reported IP status, legal issues and developments to senior management• Communication: instituted a time-efficient system to routinely interact with ARYx scientists and other personnel regarding day-to-day IP questions ("IP Helpdesk") as an adjunct to face time• Teaching: gave company-wide IP-centric presentations on such subjects as the patent process, inventorship, reading patents (understanding patent claims and determining infringement), disclosure issues, general IP agreements, etc.

Role:• Conducted various aspects of patent prosecution, including drafting applications, composing responses to USPTO Official Actions, composing Appeal Briefs, conducting patentability and freedom-to-operate searches, and drafting opinions • Maintained a docket of approximately 80 pending patent applications (50 biotechnology, including medical devices and diagnostic tests; 30 EE and ME) and performed piecemeal prosecution on another 80+ cases; filed an average of about 1 new patent application per month • Consistently billed significantly more hours than expected

Role:• Senior graduate researcher in a group of scientists who investigate the relationship between DNA structure and function in vivo and in vitro. Managerial responsibilities: Coordinate the maintenance and upkeep of the local computer network and numerous departmental computers; teach and monitor the proper use of complex laboratory instruments. Scientific responsibilities: Employ numerous molecular biochemical techniques to study the DNA structure/function relationship. • Completed Projects: See publications below.• Departmental Project: Preliminary establishment of the Keck Biophysics Facility at Northwestern University including procurement, setup (including networking), training on and maintenance of 1.7 million dollars in cutting edge biochemical and biophysical instruments. Daily management of facility now handled by a full time director. Role in facility with Director in place: computer and general consultant to the Director.